Search

Search Constraints

You searched for: Author/Creator Cameron, Scott

Search Results

3. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors. Issue 1 (15th March 2020)